Hrt Financial LP Biomea Fusion, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$4.14 - $15.3 $144,258 - $533,128
34,845 New
34,845 $156,000
Q4 2023

Feb 09, 2024
BUY
$8.37 - $19.8 $759,627 - $1.8 Million
90,756 New
90,756 $1.32 Million
Q1 2023

May 12, 2023
BUY
$6.8 - $32.35 $363,065 - $1.73 Million
53,392 Added 241.4%
75,510 $2.34 Million
Q4 2022

Feb 10, 2023
BUY
$6.3 - $11.6 $139,343 - $256,568
22,118 New
22,118 $186,000

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $189M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email